Results 21 to 30 of about 2,263,884 (199)
Ophthalmology Consultation Plan in the Context of 2019-nCoV. [PDF]
2019-nCoV is a global biochemical crisis. Ophthalmologists should remind patients to pay attention to eye protection and hand hygiene to prevent the eyes from becoming a gateway to viral infection. Prevent mutual infection between patients and patients, and between patients and doctors, disinfection and isolation of departments and operating rooms, and
Song S, Chen Y, Han Y, Wang F, Su Y.
europepmc +5 more sources
Publisher Correction: Epitopes for a 2019-nCoV vaccine. [PDF]
Lucchese G.
europepmc +4 more sources
Novel Dynamic Structures of 2019-nCoV with Nonlocal Operator via Powerful Computational Technique
In this study, we investigate the infection system of the novel coronavirus (2019-nCoV) with a nonlocal operator defined in the Caputo sense. With the help of the fractional natural decomposition method (FNDM), which is based on the Adomian decomposition
Wei Gao +3 more
doaj +3 more sources
2019 novel coronavirus (2019-nCoV) outbreak: A new challenge [PDF]
Objectives: Following the public-health emergency of international concern (PHEIC) declared by the World Health Organization (WHO) on 30 January 2020 and the recent outbreak caused by 2019 novel coronavirus (2019-nCoV) [officially renamed severe acute ...
Tommaso Lupia +5 more
doaj +3 more sources
Decisional procrastination and problematic mobile phone use: the mediation of anxiety and the moderation of 2019-nCoV traumatic experience. [PDF]
Background Decisional procrastination (DP) has a significant association with problematic mobile phone use (PMPU); however, the potential mechanisms and boundary conditions between DP and PMPU remain to be further explored.
Chen L, Gao SY, Li J, Chen LG, Huang JH.
europepmc +2 more sources
Pulmonary thrombosis in 2019-nCoV pneumonia? [PDF]
Marongiu F, Grandone E, Barcellona D.
europepmc +4 more sources
Return of the Coronavirus: 2019-nCoV [PDF]
The emergence of a novel coronavirus (2019-nCoV) has awakened the echoes of SARS-CoV from nearly two decades ago. Yet, with technological advances and important lessons gained from previous outbreaks, perhaps the world is better equipped to deal with the most recent emergent group 2B coronavirus.
Lisa E. Gralinski, Vineet D. Menachery
openaire +3 more sources
Response to 'Pulmonary thrombosis in 2019-nCoV pneumonia?' [PDF]
Tang N.
europepmc +4 more sources
Machine intelligence design of 2019-nCoV drugs
Abstract Wuhan coronavirus, called 2019-nCoV, is a newly emerged virus that infected more than 9692 people and leads to more than 213 fatalities by January 30, 2020. Currently, there is no effective treatment for this epidemic. However, the viral protease of a coronavirus is well-known to be essential for its replication and thus is an ...
Gao K, Nguyen DD, Wang R, Wei G.
europepmc +4 more sources

